These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkers. Zitterl W; Stompe T; Aigner M; Zitterl-Eglseer K; Ritter K; Zettinig G; Hornik K; Asenbaum S; Pirker W; Thau K Biol Psychiatry; 2009 Dec; 66(12):1115-22. PubMed ID: 19717141 [TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder. Stengler-Wenzke K; Müller U; Barthel H; Angermeyer MC; Sabri O; Hesse S Neuropsychobiology; 2006; 53(1):40-5. PubMed ID: 16397403 [TBL] [Abstract][Full Text] [Related]
5. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689 [TBL] [Abstract][Full Text] [Related]
6. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study. Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910 [TBL] [Abstract][Full Text] [Related]
7. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [ Lee J; Kim BH; Kim E; Howes OD; Cho KIK; Yoon YB; Kwon JS Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29210107 [TBL] [Abstract][Full Text] [Related]
10. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166 [TBL] [Abstract][Full Text] [Related]
11. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240 [TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors. Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168 [TBL] [Abstract][Full Text] [Related]
13. SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD). Pogarell O; Poepperl G; Mulert C; Hamann C; Sadowsky N; Riedel M; Moeller HJ; Hegerl U; Tatsch K Eur Neuropsychopharmacol; 2005 Oct; 15(5):521-4. PubMed ID: 16139170 [TBL] [Abstract][Full Text] [Related]
14. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density. Wolmarans de W; Brand L; Stein DJ; Harvey BH Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013 [TBL] [Abstract][Full Text] [Related]
15. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study. Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717 [TBL] [Abstract][Full Text] [Related]
16. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Pogarell O; Hamann C; Pöpperl G; Juckel G; Choukèr M; Zaudig M; Riedel M; Möller HJ; Hegerl U; Tatsch K Biol Psychiatry; 2003 Dec; 54(12):1406-13. PubMed ID: 14675805 [TBL] [Abstract][Full Text] [Related]
17. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554 [TBL] [Abstract][Full Text] [Related]